The Commission on Elections in the Philippines Selects Gemalto’s Biometrics Solution to Ensure Secure and Rapid Voter Authentication
13.5.2019 08:00:00 EEST | Business Wire | Press release
Electoral commissions have the delicate task of maintaining reliable and correct electoral registers as part of the execution of the election. To help ensure secure and accurate voter verification before issuing ballot slips, the Commission on Elections (COMELEC) in the Philippines has appointed Gemalto, a Thales company, and Nextix as technology partners to develop, deploy and support the Biometric Voter Verification System for the 2019 Philippines National and Local Election. The aim is to automate the verification of voters through the use of their biometrics information.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190512005010/en/
Secure Voter Authentication (Photo: Thales)
Addressing this need, Gemalto will provide over 30,000 biometric tablets to enable rapid identification and authentication of voters in the designated precincts across the Philippines. With the tablets that feature Gemalto’s Voter Verification System, authorities will be able to reduce fraud by verifying voters’ identity via their fingerprints. This will also help cut waiting times for the voters and authorities tremendously.
COMELEC will use the Gemalto solution to verify the identity of voters. This was put to a test at the first time during the mock elections held on 19th Jan 2019, in preparation for the actual polls in May 2019. Instead of manually checking the COMELEC’s voters list, members of the Board of Election Inspectors used the Voter Registration Verification Tablet, a system that removes the need for voters to present their identification card. Thanks to the tablet the electoral board will identify the voter's with his fingerprint to determine if the voter is registered and whether the individual belongs to the certain precinct. If the individual is a registered voter, the tablet will validate the registration and a he will receive the necessary ballot.
Fingerprints serve as a key to avoid duplication. The aim is to ensure that citizens are not able to use several identities to vote multiple times. The Voter Verification System implements a quality control to verify that the data has been captured and verified correctly. Authorities are also able to track voting activity and participation rate via logs and audit reports. These steps will ensure the best possible level of security for elections to take place.
“Secure, reliable and comprehensive enrollment and ID verification are the foundations of citizen registration, voting processes and border controls,” said Dir. James Jimenez. “With Gemalto’s Voter Verification System, we are able to streamline not only the verification but moving ahead, our registration processes bring greater convenience to citizens, guaranteeing the quality and confidentiality of data captured. We are excited to deploy this solution – a first for the Philippines government.”
“In today’s environment, authorities face numerous challenges. Biometrics serve as the primary data that establishes an individual's identity is accurately collected and verified. We are proud that the Commission on Elections (COMELEC) chose Gemalto biometric solution to verify the identity of voters. It is an honor to help COMELEC transform the agility and efficiency of the voters’ verification and registration processes.” Tan Teck Lee, Asia President, Identity & Biometric Solutions, Thales.
Note to editors
Gemalto’s solutions are at the heart of modern life, from payment to enterprise security and the internet of things. Gemalto’s technologies and services authenticate people, transactions and objects, encrypt data and create value for software – enabling businesses and governments to deliver secure digital services for billions of individuals and things.
About Thales
The people we all rely on to make the world go round – they rely on Thales. Our customers come to us with big ambitions: to make life better, to keep us safer. Combining a unique diversity of expertise, talents and cultures, our architects design and deliver extraordinary high technology solutions. Solutions that make tomorrow possible, today. From the bottom of the oceans to the depth of space and cyberspace, we help our customers think smarter and act faster - mastering ever greater complexity and every decisive moment along the way. With 80,000 employees in 68 countries, Thales reported sales of €19 billion in 2018.
PLEASE VISIT
Thales
Group
Digital
Security
Download
HD photos
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190512005010/en/
Contact information
PRESS
Thales, Media Relations
Security
Constance
Arnoux
+33 (0)6 44 12 16 35
constance.arnoux@thalesgroup.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use4.5.2026 18:16:00 EEST | Press release
Kubota Vision Inc. (“Kubota Vision”), a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japan) announced signing of a Supply and Licensing Agreement with Laboratoires KÔL (Clermont-Ferrand, France) for the provision of a Stargardt disease (STGD1) treatment candidate under compassionate use authorization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414590785/en/ The purpose of this Agreement is for Kubota Vision and KÔL to collaborate on providing “Emixustat” for treatment of Stargardt Disease (STGD1) through compassionate use authorization in France. Kubota Vision will exclusively manufacture and supply Emixustat final products to KÔL and KÔL will have exclusive rights to distribute Emixustat in France under compassionate use access. Ryo Kubota, Chairman, President, and CEO of Kubota Pharmaceutical Holdings, stated, “We are extremely pleased to enter into this Agreement with Labor
Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 17:28:00 EEST | Press release
With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f
Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 16:00:00 EEST | Press release
Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading transformative and meaningful customer experiences. These leading organizations are turning everyday interactions into seamless, cross-channel journeys that deliver meaningful business impact and
Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 16:00:00 EEST | Press release
Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On the demand side, with smart meter integration, Predict+ models each meter individually and performs extensive calculations on actual, historical, and average data to acc
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 15:30:00 EEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
